Creative Planning’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Buy
27,754
+16,869
+155% +$119K ﹤0.01% 3755
2026
Q1
$70.1K Sell
10,885
-5,592
-34% -$43.2K ﹤0.01% 3958
2025
Q4
$135K Sell
16,477
-5,926
-26% -$53.5K ﹤0.01% 3660
2025
Q3
$199K Sell
22,403
-24,622
-52% -$156K ﹤0.01% 3488
2025
Q2
$246K Buy
47,025
+6,171
+15% +$31.4K ﹤0.01% 3065
2025
Q1
$221K Sell
40,854
-2,321
-5% -$11K ﹤0.01% 2982
2024
Q4
$197K Sell
43,175
-5,327
-11% -$27.3K ﹤0.01% 2975
2024
Q3
$252K Buy
48,502
+8,502
+21% +$38.4K ﹤0.01% 2667
2024
Q2
$110K Hold
40,000
﹤0.01% 2822
2024
Q1
$99.6K Hold
40,000
﹤0.01% 2710
2023
Q4
$107K Hold
40,000
﹤0.01% 2562
2023
Q3
$47.6K Hold
40,000
﹤0.01% 2487
2023
Q2
$67.6K Hold
40,000
﹤0.01% 2406
2023
Q1
$41.6K Hold
40,000
﹤0.01% 2367
2022
Q4
$31.2K Buy
+40,000
New +$41.9K ﹤0.01% 2286

Other funds holding AVAH

Creative Planning's AVAH Position: Q2 2026 in Review

Creative Planning increased its Aveanna Healthcare (AVAH) stake by 155% in Q2 2026, buying an estimated $119K and bringing the position to 27,754 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #3755.

Creative Planning first reported a position in AVAH in Q4 2022 and has held it in 15 quarters since. The position peaked at $252K in Q3 2024. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • Creative Planning held 27,754 shares of Aveanna Healthcare worth $238K as of Q2 2026.
  • Creative Planning bought 16,869 Aveanna Healthcare shares in Q2 2026, an estimated $119K.
  • Aveanna Healthcare made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3755 holding.
  • Creative Planning first reported a position in Aveanna Healthcare in Q4 2022 and has held it in 15 quarters since.
  • Creative Planning's Aveanna Healthcare position peaked at $252K in Q3 2024.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.